Mitsubishi UFJ Asset Management’s Fate Therapeutics FATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-71,101
Closed -$249K 1598
2024
Q3
$249K Sell
71,101
-6,715
-9% -$26.1K ﹤0.01% 937
2024
Q2
$255K Buy
+77,816
New +$341K ﹤0.01% 932
2023
Q4
Sell
-60,299
Closed -$128K 1569
2023
Q3
$128K Buy
60,299
+7,916
+15% +$26.2K ﹤0.01% 1059
2023
Q2
$249K Buy
52,383
+39,734
+314% +$219K ﹤0.01% 1012
2023
Q1
$72.1K Hold
12,649
﹤0.01% 1100
2022
Q4
$129K Buy
12,649
+1,597
+14% +$30K ﹤0.01% 1065
2022
Q3
$248K Sell
11,052
-19
-0.2% -$549 ﹤0.01% 1000
2022
Q2
$274K Buy
11,071
+5,511
+99% +$152K ﹤0.01% 1007
2022
Q1
$216K Buy
5,560
+330
+6% +$12.8K ﹤0.01% 1043
2021
Q4
$315K Buy
5,230
+1,119
+27% +$63.4K ﹤0.01% 1001
2021
Q3
$244K Hold
4,111
﹤0.01% 1033
2021
Q2
$357K Sell
4,111
-3,047
-43% -$246K ﹤0.01% 1005
2021
Q1
$590K Buy
7,158
+2,325
+48% +$223K ﹤0.01% 861
2020
Q4
$439K Sell
4,833
-1,843
-28% -$114K ﹤0.01% 848
2020
Q3
$267K Sell
6,676
-42
-0.6% -$1.47K ﹤0.01% 863
2020
Q2
$230K Sell
6,718
-5,537
-45% -$165K ﹤0.01% 869
2020
Q1
$272K Buy
12,255
+2,480
+25% +$62.7K ﹤0.01% 815
2019
Q4
$187K Buy
9,775
+1,955
+25% +$31K ﹤0.01% 881
2019
Q3
$121K Buy
7,820
+1,529
+24% +$29.3K ﹤0.01% 882
2019
Q2
$128K Sell
6,291
-6,333
-50% -$114K ﹤0.01% 893
2019
Q1
$222K Buy
12,624
+1,139
+10% +$18K ﹤0.01% 783
2018
Q4
$151K Sell
11,485
-3,116
-21% -$43.4K ﹤0.01% 787
2018
Q3
$238K Buy
+14,601
New +$173K ﹤0.01% 756

Other funds holding FATE